Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
: Responsibilities will include: Performing literature reviews to identify key gaps in current knowledge Supporting federal and provincial report research and writing activities Developing analytic plans and
-
: Under the direction of the Associate Director, Industry Partnerships, the Senior Industry Partnerships Officer is responsible for the planning, development, and management of complex research grants, as
-
. Demonstrated ability to prepare meeting agendas and to take and write minutes. Attention to detail and a proven ability to draft correspondence and to proofread documents using appropriate spelling, grammar
-
opportunities to improve existing financial processes and participate in the development of new policies, procedures and guidelines that support the Faculty’s initiatives and ensure smooth implementation. Advise
-
. They guide students in navigating the McGill student experience through orientation and transition programming and by providing student life opportunities across campus for students to develop their interests
-
the communication plan and assist with implementation as directed. Review CL&E and other SLL Unit’s calendars of events to prepare communications materials. Keep abreast of trends or events in other SLL units and
-
Development and compilation of key performance indicators (KPIs) o Quality improvement projects (various) (i.e., process mapping, policy/procedure development) o Learning and Development (educational
-
the Division of Nephrology are also expected to contribute to our interdisciplinary education mission, supporting the education and professional development of nurses and nurse practitioners. Clinician
-
build links with other McGill institutions. The incumbent will be expected to develop and promote clinical innovation in the Division of Dermatology and is expected to contribute to clinical research and
-
sites into a unified program designed to make D2R a global leader in the discovery, development and delivery of genomics-based RNA therapeutics. The initiative focuses on health outcomes for overlooked